Max Robotics — Global Service Robot Directory + US Certification

About

The Netherlands Cancer Institute (NKI) stands as one of Europe's premier oncology research institutions, distinguished by its deep commitment to advancing cancer diagnostics, surgical innovation, and precision medicine. Located in Amsterdam, NKI seamlessly integrates clinical excellence with cutting-edge research, making it a global reference point for urological oncology and image-guided surgical technologies. NKI's research portfolio spans minimally invasive surgery, robotic-assisted procedures, and fluorescence-guided interventions. The institute has been instrumental in shaping international clinical standards, as evidenced by its contributions to European Association of Urology guidelines on bladder and renal cell carcinoma—papers that have collectively garnered over a thousand citations and directly inform clinical practice worldwide. Their pioneering work on sentinel lymph node identification using hybrid multimodal tracers, combining radioguided and fluorescence imaging, has redefined intraoperative precision in prostate cancer surgery and beyond. A particularly notable area of strength is robotic surgery training and curriculum development. NKI researchers have co-authored landmark consensus statements and validation studies—including the Pasadena Consensus Panel recommendations and the ERUS robotic training curricula—that have established globally recognized standards for surgical education. Their DROP-IN gamma probe and hybrid imaging technologies represent transformative innovations enabling robot-assisted radioguided surgery with unprecedented maneuverability. NKI also contributes to the frontier of artificial intelligence in the operating room and whole genome sequencing for cancer diagnostics, reflecting a broad translational vision. With consistently high-impact publications and robust international collaborations, NKI offers prospective students and partners a uniquely dynamic environment where surgical robotics, molecular imaging, and oncological science converge to redefine cancer care.